• 15 Apr, 2026
Gland Pharma Brings Back Naina Lal Kidwai as Independent Director for Another 5 Years

Gland Pharma Brings Back Naina Lal Kidwai as Independent Director for Another 5 Years

In the fast paced world of Indian pharmaceuticals, strong leadership are not just nice to have they are essential for long term success. On April 9, 2026 Gland Pharma Limited made a strategic announcement that reinforces exactly that: re appointment of Naina Lal Kidwai, a trailblazing banker and seasoned board leader, as Independent Director for a second consececutive five year term.

Gland Pharma’s ₹6.29 Crore GST Dispute: What Investors Need to Know Introduction

Explore Gland Pharma’s ₹6.29 crore GST dispute from Telangana authorities over export reclassifications and credit notes for FY 2019-20. The company deems it unjustified and plans an appeal, assuring no major impact. Dive into company overview, market reactions, stock performance, and broader pharma sector implications as of March 9, 2026. Solid fundamentals persist amid short-term volatility.

Read More